Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.

Avoiding therapeutic pitfalls: the rational use of specifically targeted agents against hepatitis C infection.

McGovern BH, Abu Dayyeh BK, Chung RT.

Hepatology. 2008 Nov;48(5):1700-12. doi: 10.1002/hep.22563. Erratum in: Hepatology. 2009 Mar;49(3):1059.

PMID:
18972443
2.

[Treatment of hepatitis C virus infection in patients with concurrent human immunodeficiency virus infection].

Peters L, Lindhardt BØ.

Ugeskr Laeger. 2006 Oct 16;168(42):3604-8. Review. Danish.

PMID:
17069721
3.

Hepatitis C treatment, HAART and side effects.

[No authors listed]

TreatmentUpdate. 2001 Nov-Dec;13(7):7-8. No abstract available.

PMID:
11794865
4.

New paradigms in the management of hepatitis C virus co-infections.

Sherman KE.

Nat Clin Pract Gastroenterol Hepatol. 2007 Jan;4 Suppl 1:S10-6. Review.

PMID:
17235280
5.

Management of hepatitis C virus coinfection in HIV-infected persons.

O'Leary JG, Chung RT.

AIDS Read. 2006 Jun;16(6):313-6, 318-20. Review.

PMID:
16795921
6.

Care of patients with hepatitis C and HIV co-infection.

Soriano V, Puoti M, Sulkowski M, Mauss S, Cacoub P, Cargnel A, Dieterich D, Hatzakis A, Rockstroh J.

AIDS. 2004 Jan 2;18(1):1-12. Review. No abstract available.

PMID:
15090824
7.

Treatment of hepatitis C virus infection.

Weigand K, Stremmel W, Encke J.

World J Gastroenterol. 2007 Apr 7;13(13):1897-905. Review.

8.

Psychiatric behavioral aspects of comanagement of hepatitis C virus and HIV.

Weiss JJ, Gorman JM.

Curr HIV/AIDS Rep. 2006 Nov;3(4):176-81. Review.

9.

Chronic hepatitis C in HIV-infected patients: those who more need therapy are those who respond less.

Soriano V, Nuñez M, Garcia-Samaniego J, Labarga P, Simarro N, Martín-Carbonero L, Romero M, Ramos B, Barreiro P.

Infect Disord Drug Targets. 2006 Mar;6(1):57-88. Review.

PMID:
16787304
10.

[Current treatment of hepatitis C virus infection].

Lörke J, Avci A, Erhardt A, Heintges T, Häussinger D.

Dtsch Med Wochenschr. 2005 Jul 29;130(30):1773-7. Review. German.

PMID:
16049884
11.

New advances in hepatitis C therapy.

[No authors listed]

Proj Inf Perspect. 2000 Aug;(30):18-9.

PMID:
12171011
12.

[Genotype 1 superresponder treat for only 24 weeks].

[No authors listed]

MMW Fortschr Med. 2005 Dec 15;147(51-52):69. German. No abstract available.

PMID:
16402717
13.

HIV & hepatitis C: treatment.

[No authors listed]

WORLD. 2002 May;(133):4-5. No abstract available.

PMID:
12064298
14.

Interferon for hepatitis C patients with psychiatric disorders.

Asnis GM, De La Garza R, Rego SA, Henderson MA, Reinus JF.

Am J Psychiatry. 2004 Dec;161(12):2332; author reply 2332-4. No abstract available.

PMID:
15569920
15.

New paradigms in the management of HIV and hepatitis C virus coinfection.

Soriano V, Martin-Carbonero L, Maida I, Garcia-Samaniego J, Nuñez M.

Curr Opin Infect Dis. 2005 Dec;18(6):550-60. Review.

PMID:
16258331
16.

HCV infection in the setting of HIV: prevalence, disease, treatment.

Laurence J.

AIDS Read. 2006 Mar;16(3):115-6. No abstract available.

PMID:
16538952
17.
18.

Clinical trials of treatment for hepatitis C virus infection in HIV-infected patients: past, present, and future.

Shire NJ, Sherman KE.

Clin Infect Dis. 2005 Jul 1;41 Suppl 1:S63-8. Review.

PMID:
16265616
19.

Peginterferon-alpha(2b) and ribavirin.

Ahn J, Flamm S.

Expert Rev Anti Infect Ther. 2004 Feb;2(1):17-25. Review.

PMID:
15482168
20.

[Systemic lupus erythematosus syndrome induced by interferon therapy].

Martínez Alfaro E, Mateos Rodríguez F, Blanch Sancho JJ, Tárraga Rodríguez I.

Med Clin (Barc). 2004 Oct 30;123(15):597. Spanish. No abstract available.

PMID:
15535949

Supplemental Content

Support Center